Olio Labs

Olio Labs is pioneering a novel approach to drug development, leveraging artificial intelligence to create combination therapeutics designed to address complex diseases. Unlike traditional methods that focus on individual targets, Olio Labs considers the intricate network of thousands of interacting proteins within the human body. Their primary focus is on developing combination therapies for obesity, aiming to provide more effective results with reduced side effects compared to existing treatments like Ozempic. By utilizing custom-built machine learning algorithms, informed by real-world expertise and cutting-edge AI, Olio Labs explores trillions of potential combinations to identify optimal therapeutic solutions.